Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Daniel D. Von Hoff, M. Christine Cripps et al.|Journal of Clinical Oncology|1997

Cited by 5.9k